— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected. — Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected. — Worldwide Consumer net sales increased 3.3% to $961 million. — Prescription Pharmaceuticals sales improved 13.6% to $230 million. — FY19 GAAP EPS is expected to be […]
“— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected. — Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected. — Worldwide Consumer net sales increased 3.3% to $961 million. — Prescription Pharmaceuticals sales improved 13.6% to $230 million. — FY19 GAAP EPS is expected to be […]
· November 6, 2019
— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected.
— Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected.
— Worldwide Consumer net sales increased 3.3% to $961 million.
— Prescription Pharmaceuticals sales improved 13.6% to $230 million.
— FY19 GAAP EPS is expected to be $2.01-2.21.
— FY19 adjusted EPS is expected to be $3.85-4.05.
— PRGO shares gained 0.98% following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
